Susan Bressman

1982–2025 年に発表

122
論文数
23,638
被引用数
87
h 指数
120
i10 指数

被引用数

Susan Bressman の年別被引用数1967 年: 被引用 1 件1981 年: 被引用 1 件1986 年: 被引用 6 件1987 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 3 件1990 年: 被引用 8 件1991 年: 被引用 18 件1992 年: 被引用 6 件1993 年: 被引用 9 件1994 年: 被引用 17 件1995 年: 被引用 32 件1996 年: 被引用 23 件1997 年: 被引用 36 件1998 年: 被引用 58 件1999 年: 被引用 37 件2000 年: 被引用 66 件2001 年: 被引用 74 件2002 年: 被引用 106 件2003 年: 被引用 97 件2004 年: 被引用 134 件2005 年: 被引用 95 件2006 年: 被引用 130 件2007 年: 被引用 164 件2008 年: 被引用 139 件2009 年: 被引用 260 件2010 年: 被引用 236 件2011 年: 被引用 231 件2012 年: 被引用 189 件2013 年: 被引用 248 件2014 年: 被引用 196 件2015 年: 被引用 180 件2016 年: 被引用 202 件2017 年: 被引用 219 件2018 年: 被引用 222 件2019 年: 被引用 645 件2020 年: 被引用 670 件2021 年: 被引用 695 件2022 年: 被引用 549 件2023 年: 被引用 417 件2024 年: 被引用 618 件2025 年: 被引用 276 件2026 年: 被引用 8 件1968〜1980 年は被引用が無いため表示していません1982〜1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,268 件、この内訳の 26.3%イギリス: 引用元論文 784 件、この内訳の 9.1%ドイツ: 引用元論文 666 件、この内訳の 7.7%イタリア: 引用元論文 555 件、この内訳の 6.4%中国: 引用元論文 419 件、この内訳の 4.9%カナダ: 引用元論文 416 件、この内訳の 4.8%フランス: 引用元論文 342 件、この内訳の 4%スペイン: 引用元論文 250 件、この内訳の 2.9%オーストラリア: 引用元論文 231 件、この内訳の 2.7%オランダ: 引用元論文 225 件、この内訳の 2.6%イスラエル: 引用元論文 185 件、この内訳の 2.2%日本: 引用元論文 185 件、この内訳の 2.2%
0%26.3%その他 24.2%

分野

  • Medicine66.6%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Neuroscience9.8%
  • Computer Science1.8%
  • Health Professions1.1%
  • Psychology1.1%
  • その他2.3%

トピック

  • Parkinson's Disease Mechanisms and Treatments15.4%
  • Neurological disorders and treatments10.5%
  • Botulinum Toxin and Related Neurological Disorders4.6%
  • Genetic Neurodegenerative Diseases4%
  • Neurological diseases and metabolism2.9%
  • Lysosomal Storage Disorders Research2.9%
  • その他59.7%

共著者

全論文

検索で開く
  1. Phenomenology and classification of dystonia: A consensus update

    著者: , , , , , , , , , , , , - Movement Disorders 2013 被引用: 2,247

  2. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2008 被引用: 1,563

  3. Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease

    著者: , , , , , , - JAMA Neurology 2018 被引用: 406

  4. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Todd Lencz, Richard H. Myers, Harry Ostrer, Laurie J. Ozelius, Haydeh Payami, Yakov Peter, John D. Rioux, Anthony W. Segal, William K. Scott, Mark S. Silverberg, Jeffery M. Vance, Iban Ubarretxena‐Belandia, Tatiana Foroud, Gil Atzmon, Itsik Pe’er, Yiannis A. Ioannou, Dermot McGovern, Zhenyu Yue, Eric E. Schadt, Judy H. Cho, Inga Peter - Science Translational Medicine 2018 被引用: 408

  5. Differential effects of severe vs mild GBA mutations on Parkinson disease

    著者: , , , , , , , , , - Neurology 2015 被引用: 374

  6. Analysis of blink rate patterns in normal subjects

    著者: , , , , , - Movement Disorders 1997 被引用: 509

  7. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher G. Goetz - Annals of Neurology 2022 被引用: 99

  8. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Yu. Fedotova, Natalya Abramycheva, Victoria Álvarez, Manuel Menéndez‐González, S. Jesús Maestre, Pilar Gómez‐Garre, Pablo Mir, Andrea Carmine Belin, Caroline Ran, Chin‐Hsien Lin, Ming‐Che Kuo, David Crosiers, Zbigniew K. Wszołek, Owen A. Ross, Joseph Jankovic, Kenya Nishioka, Manabu Funayama, Jordi Clarimón, Caroline H. Williams‐Gray, Marta Camacho, Mario Cornejo‐Olivas, Luis Torres-Ramírez, Yih‐Ru Wu, Guey‐Jen Lee‐Chen, Ana Morgadinho, Teeratorn Pulkes, Pichet Termsarasab, Daniela Berg, Gregor Kuhlenbäumer, Andrea A. Kühn, Friederike Borngräber, Giuseppe De Michele, Anna De Rosa, Alexander Zimprich, Andreas Puschmann, George D. Mellick, Jolanta Dorszewska, Jonathan Carr, Rosangela Ferese, Stefano Gambardella, Bruce A. Chase, Katerina Markopoulou, Wataru Satake, Tatsushi Toda, Malco Rossi, Marcelo Merello, Timothy Lynch, Diana A. Olszewska, Shen‐Yang Lim, Azlina Ahmad‐Annuar, Ai Huey Tan, Bashayer Al‐Mubarak, Haşmet Hanağası, Dariusz Koziorowski, Sibel Ertan, Gençer Genç, Patrícia de Carvalho Aguiar, Melinda Barkhuizen, Márcia Mattos Gonçalves Pimentel, Rachel Saunders‐Pullman, Bart van de Warrenburg, Susan Bressman, Mathias Toft, Silke Appel‐Cresswell, Anthony E. Lang, Matěj Škorvánek, Agnita J.W. Boon, Rejko Krüger, Esther Sammler, Vítor Tumas ほか 35 名 - Movement Disorders 2023 被引用: 49

  9. Validity and reliability of a rating scale for the primary torsion dystonias

    著者: , , , , , - Neurology 1985 被引用: 1,111

  10. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression

    著者: , , , , , , , , , , , , , , - JAMA Network Open 2021 被引用: 86

  11. Progression in the LRRK2-Associated Parkinson Disease Population

    著者: , , , , , , , , , , , , , , - JAMA Neurology 2018 被引用: 156

  12. Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cynthia Casaceli, Shilpa C. Rao, Kamalini Ghosh Galvelis, Anna Naito, James C. Beck, Roy N. Alcalay - Brain 2024 被引用: 89

  13. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2017 被引用: 169

  14. Arm swing as a potential new prodromal marker of Parkinson's disease

    著者: , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2016 被引用: 180

  15. Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers

    著者: , , , , , , , , , , , , , , , , , , , , , - Neurology 2016 被引用: 138

  16. Long-Term Dementia Risk in Parkinson Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Siderowf, Douglas Galasko, Lana Chahine, Christopher S. Coffey, Kalpana Merchant, Kathleen L. Poston, Roseanne D. Dobkin, Tatiana Foroud, Brit Mollenhauer, Dan Weintraub, Ethan Brown, Karl Kieburtz, Duygu Tosun, Werner Poewe, Susan Bressman, Jan Hamer, Raymond James, Ekemini Riley, John Seibyl, Leslie M. Shaw, David G. Standaert, Sneha Mantri, Nabila Dahodwala, Michael A. Schwarzschild, Connie Marras, Hubert Fernandez, Ira Shoulson, Helen Rowbotham, Lucy Norcliffe‐Kaufmann, Paola Casalin, Claudia Trenkwalder, Todd Sherer, Sohini Chowdhury, Mark Frasier, Jamie L. Eberling, Katie Kopil, Alyssa O’Grady, James Gibaldi, Maggie Kuhl, L. Kirsch, Emily Flagg, Bridget McMahon, Craig Stanley, Kim Fabrizio, Dixie Ecklund, Trevis Huff, Richard M. Peters, Janel Fedler, Laura Heathers, Christopher Hobbick, Gena Antonopoulos, Chelsea Caspell‐Garcia, Michael C. Brumm, Arthur W. Toga, Karen Crawford, Andrew Singleton, Thomas J. Montine, Monica Korell, Ruth B. Schneider, Kelvin L. Chou, David Russell, Stewart A. Factor, Penelope Hogarth, Robert A. Hauser, Marie Saint‐Hilaire, David Shprecher, Kathrin Brockmann, Yen Tai, Paolo Barone, Stuart Isaacson ほか 82 名 - Neurology 2024 被引用: 74

  17. Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease

    著者: , , , , , , , , , , , - Journal of Parkinson s Disease 2021 被引用: 33

  18. Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorraine N. Clark, Karen Marder, Tanya Gurevich, Anat Bar Shira, Mali Gana Weisz, Kira Yasinovsky, Maayan Zalis, Avner Thaler, Yaacov Balash, Shabtai Hertzel, Ziv Gan‐Or, Hila Kobo, Ariella Hillel, Anat Shkedy, Avi Orr‐Urtreger, Nir Giladi, Andres Deik, Matthew J. Barrett, Jose Cabassa, Mark Groves, Ann Hunt, Naomi Lubarr, Marta San Luciano, Joan Miravite, Christina A Palmese, Rivka Sachdev, Harini Sarva, Lawrence Severt, Vicki Shanker, Matthew Swan, Jeannie Soto‐Valencia, Brooke Johannes, Robert Ortega, Laurie J. Ozelius, Rachel Saunders‐Pullman, Deborah Raymond, Susan Bressman - Neurology 2015 被引用: 168

  19. Metabolomic profiling to develop blood biomarkers for Parkinson's disease

    著者: , , , , , , - Brain 2008 被引用: 404

  20. Cognitive performance of GBA mutation carriers with early-onset PD

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bradley C. Hiner, Andrew Siderowf, Haydeh Payami, Eric Molho, Stewart A. Factor, Ruth Ottman, Lorraine N. Clark, Karen Marder - Neurology 2012 被引用: 268

  21. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nichole Daegele, Cynthia Casaceli, Ray Dorsey, Renée Wilson, Sugi Mahes, Christina M. Salerno, Karen Crawford, Paola Casalin, Giulia Malferrari, Mali Gani Weisz, Avi Orr‐Urtreger, Thomas J. Montine, Chris Baglieri, Amanda Christini, David Russell, Nabila Dahodwala, Nir Giladi, Stewart A. Factor, Penelope Hogarth, David G. Standaert, Robert A. Hauser, Joseph Jankovic, Marie Saint‐Hilaire, Irene Hegeman Richard, David Shprecher, Hubert Fernandez, Katrina Brockmann, Liana S. Rosenthal, Paolo Barone, Alberto J. Espay, Dominic B. Rowe, Karen Marder, A. Parra Santiago, Shu‐Ching Hu, Stuart Isaacson, Jean‐Christophe Corvol, Javiar Ruiz Martinez, Eduardo Tolosa, Yen Tai, Marios Politis, Debra Smejdir, Linda Rees, Karen Williams, Farah Kausar, Karen Williams, Whitney Richardson, Diana Willeke, Shawnees Peacock, Barbara Sommerfeld, Alison Freed, Katrina Wakeman, Courtney Blair, Stephanie Guthrie, Leigh Harrell, Christine Hunter, Cathi-Ann Thomas, Raymond James, Grace A. Zimmerman, Victoria Brown, Jennifer Mule, Ella Hilt, Kori Ribb, Susan Ainscough, Misty Wethington, Madelaine Ranola, Helen Mejia Santana, Juliana Moreno, Deborah Raymond, Krista Speketer, Lisbeth Carvajal ほか 34 名 - The Lancet Neurology 2019 被引用: 139

  22. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease

    著者: , , , , , , , , , , , , , , , - Neurology 2013 被引用: 178

  23. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein

    著者: , , , , , , , , , , , , , , - Nature Genetics 1997 被引用: 1,020

  24. LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2006 被引用: 671